Genetic Technologies Limited
OTC: GNTLF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Kevin Camilleri
- Employees
- 55
- Headquarters
- Fitzroy, Australia
- IPO year
- 2000
- Market cap
- $1.3B
- Website
- https://www.gtglabs.com
Loading GNTLF…
Loading profile data…Frequently asked questions about GNTLF
What does Genetic Technologies Limited (GNTLF) do?
Genetic Technologies Limited, trading as GNTLF, is an Australian molecular diagnostics enterprise dedicated to creating and delivering advanced predictive assessment instruments. These tools are designed to assist medical professionals in Australia and the United States with managing women's health. The company's primary offering is BREVAGenplus...
Where does GNTLF trade?
Genetic Technologies Limited (GNTLF) trades on the Other OTC.
What sector is GNTLF in?
Genetic Technologies Limited (GNTLF) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of Genetic Technologies Limited?
Kevin Camilleri is the chief executive officer of Genetic Technologies Limited (GNTLF).
Where is Genetic Technologies Limited headquartered?
Genetic Technologies Limited is headquartered in Australia.
Does GNTLF pay a dividend?
Genetic Technologies Limited (GNTLF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did GNTLF go public?
Genetic Technologies Limited (GNTLF) completed its initial public offering in 2000.